The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Monsanto Company's Global Performance Drives 25 Percent 2012 Ongoing Earnings Per Share Growth; Company Underscores Mid-Teens Ongoing Earnings Per Share Growth Opportunity In 2013

Wednesday, October 03, 2012

Monsanto Company's Global Performance Drives 25 Percent 2012 Ongoing Earnings Per Share Growth; Company Underscores Mid-Teens Ongoing Earnings Per Share Growth Opportunity In 201308:00 EDT Wednesday, October 03, 2012Company Projects 2013 Ongoing and As-Reported Earnings Per Share Guidance of $4.18 to $4.32ST. LOUIS, Oct. 3, 2012 /PRNewswire/ -- Monsanto Company (NYSE: MON) today announced it concluded fiscal year 2012 with ongoing earnings per share growth of 25 percent, and added that it is well-positioned to attain mid-teens ongoing earnings per share growth next year. The company delivered growth in its base business in the United States on the continued adoption of its key corn and soybean platforms, complemented by international seeds and traits performance. Executives also highlighted early 2012 U.S. corn harvest results, which reinforce Monsanto's long-standing yield advantage even in one of the most difficult growing seasons on record.Fourth QuarterFiscal Year($ in millions)2012201120122011Net Sales By SegmentCorn seed and traits$588$671$5,814$4,805Soybean seed and traits142961,7711,542Cotton seed and traits29181779847Vegetable seeds284267851895All other crops seeds and traits172136586493TOTAL Seeds and Genomics$1,215$1,351$9,801$8,582Agricultural productivity$895$896$3,715$3,240TOTAL Agricultural Productivity$895$896$3,715$3,240TOTAL Net Sales$2,110$2,247$13,516$11,822Gross Profit$881$972$7,045$6,079Operating Expenses$1,137$1,042$3,897$3,577Interest Expense ? Net$34$22$114$88Other Expense (Income) ? Net $?$2$46$40Net Income (Loss) Attributable to Monsanto Company$(229)$(112)$2,045$1,607Diluted Earnings (Loss) per Share (See note 1.)$(0.42)$(0.21)$3.79$2.96Items Affecting Comparability ? EPS ImpactRestructuring charges, net$(0.02)$(0.01)$(0.02)$?Income on discontinued operations??(0.01)?Nitro claims settlement??0.05?Resolution of a legacy tax matter??(0.11)?Diluted Earnings (Loss)  per Share from Ongoing Business (For the definition of ongoing EPS, see note 1.)$(0.44)$(0.22)$3.70$2.96Effective Tax Rate24%3%30%30%  Fourth QuarterFiscal YearComparison as a Percent of Net Sales:2012201120122011Gross profit42%43%52%51%Selling, general and administrative expenses (SG&A)34%29%18%19%Research and development expenses21%18%11%12%Income (Loss) from continuing operations before income taxes (14)%(4)%22%20%Net income (Loss) attributable to Monsanto Company(11)%(5)%15%14%"We've proven our business on a global stage with back-to-back years of tremendous performance and momentum," said Hugh Grant, chairman and chief executive officer for Monsanto. "With more waves of innovation and global opportunities than ever before, I'm confident that by building off what we accomplished in 2012 we can achieve steady growth in fiscal year 2013 as we continue to deliver sustainable yield to our farmer customers."Results of OperationsMonsanto reported net sales of $2.1 billion for the fourth quarter of fiscal year 2012.  Net sales for the full fiscal year were $13.5 billion, a 14 percent increase over fiscal year 2011. Full year net sales results were driven primarily by higher global corn seeds and traits revenue, and increased soybean seeds and traits revenue in the United States and Brazil. Seeds and Genomics segment net sales were $1.2 billion for the quarter, a decrease from the prior year.  For the fiscal year, net sales for the Seeds and Genomics segment reached $9.8 billion, a 14 percent increase over the prior year. Agricultural Productivity segment net sales were $895 million for the quarter.  Net sales for the Agricultural Productivity segment for the fiscal year grew to $3.7 billion.  Monsanto reported a net loss of $229 million in the fourth quarter of fiscal year 2012, compared with a reported net loss of $112 million in the same period last year.  Net income for fiscal year 2012 was $2 billion, an increase over fiscal year 2011 net income of $1.6 billion. The company's fiscal year 2012 earnings per share (EPS) was $3.70 on an ongoing basis and $3.79 on an as-reported basis.  For the fourth quarter, the company reported a loss per share of $0.44 on an ongoing basis and $0.42 on an as-reported basis.  (For a reconciliation of ongoing EPS, see page 1 and note 1.)Cash FlowFor fiscal year 2012, net cash provided by operating activities was a source of $3 billion, compared with a source of $2.8 billion in fiscal year 2011. Net cash required by investing activities was $1 billion in fiscal year 2012, compared with net cash required of $975 million last year. Net cash required by financing activities was $1.2 billion for fiscal year 2012, compared with net cash required of $864 million in fiscal year 2011. Free cash flow was a source of $2 billion for fiscal year 2012, compared to a source of $1.8 billion in fiscal year 2011. (For a reconciliation of free cash flow, see note 1.)  OutlookIn fiscal year 2013, Monsanto expects to achieve mid-teens ongoing EPS growth off the 2012 base of $3.70 for a range of $4.18 to $4.32. The company expects as-reported EPS to also be in the range of $4.18 to $4.32.  (For a reconciliation of 2013 EPS guidance, see note 1.) The Seeds and Genomics segment is expected to deliver gross profit in the range of $6.55 billion in 2013, with gross profit growth projected to be divided roughly evenly between the United States and international regions. Gross profit for the Agricultural Productivity segment next year is expected in the range of $1 billion.The company projects free cash flow in the range of $1.7 billion to $1.8 billion for fiscal year 2013.  The company expects net cash provided by operating activities to be $2.8 billion to $3.1 billion, and net cash required by investing activities to be approximately $1.1 billion to $1.3 billion for fiscal year 2013. (For a reconciliation of free cash flow, see note 1.)  In fiscal year 2013, the company expects selling, general and administrative expenses to be in the range of $2.55 billion. The company's research and development spend is projected in the range of $1.53 billion for fiscal year 2013.Seeds and Genomics Segment Detail($ in millions)Net SalesGross ProfitSeeds and GenomicsFourth QuarterFiscal YearFourth QuarterFiscal Year20122011201220112012201120122011Corn Seed and Traits$588$671$5,814$4,805$284$340$3,589$2,864Soybean Seed and Traits142961,7711,54281921,1601,045Cotton Seed and Traits2918177984718140585642Vegetable Seeds284267851895159173419534All Other Crops Seeds and Traits1721365864938945306221TOTAL Seeds and Genomics$1,215$1,351$9,801$8,582$631$790$6,059$5,306 ($ in millions)Earnings (Loss) Before Interest & Taxes (EBIT)Fourth QuarterFiscal YearSeeds and Genomics2012201120122011EBIT (For a reconciliation of EBIT, see note 1.)$(387)$(157)$2,570$2,106Unusual Items Affecting EBIT: Restructuring$10$4$10$(11) The Seeds and Genomics segment consists of the company's global seeds and related traits business. For the fiscal year, Monsanto realized Seeds and Genomics segment sales of $9.8 billion, reflecting a 14 percent increase over the prior year. Segment sales in the fourth quarter were $1.2 billion, a decrease from the prior year period. In the United States, branded seed volume in fiscal year 2012 grew by the largest increment in three years and outpaced market expansion. In corn, the company reached 27 million planted U.S. acres for its Genuity® Reduced Refuge Family. While harvest is still in progress, the company shared some early highlights of what the 2012 U.S. corn harvest has shown to date:In a year when average corn yields are significantly down, DEKALB® continues its historic advantage relative to competitive products. In 2012, DEKALB® is outperforming competitive products with approximately a 8 bushels per acre national yield advantage, with Monsanto's germplasm providing greater consistency in performance amidst this season's drought conditions. Results to date by region also show an advantage over competitors for DEKALB®, including approximately a 9 bushels per acre yield advantage in the Central Corn Belt and approximately a 8 bushels per acre yield advantage in the Southern Region. Monsanto's Genuity® DroughtGard? Hybrids system, which combines germplasm selected for its drought-tolerant characteristics, the drought-tolerant biotechnology trait and agronomic recommendations, has demonstrated strong performance in Ground Breakers? on-farm testing this season. Compared head-to-head to competitor hybrids marketed to the drought segment, DroughtGard? Hybrids results across the Western Great Plains show approximately a 5 bushels per acre yield advantage to date.  In 2013, the company is targeting 36 million to 38 million acres for the Reduced Refuge Family. Genuity® VT Triple PRO® RIB Complete®, a convenient, single-bag refuge option, will join Genuity® SmartStax® RIB Complete® and Genuity® VT Double PRO® RIB Complete® corn blends as an additional product choice available for the 2013 season. The DroughtGard? Hybrids system will also be introduced in 2013 in the Western Great Plains under stewardship requirements pending import approvals in key export markets.In soybeans, the company reached a total of 32 million acres for its Genuity® Roundup Ready 2 Yield® product in the United States. The company expects the Genuity® Roundup Ready 2 Yield® platform growth to continue, targeting 39 million to 41 million acres in 2013.In 2013, the company expects Latin America to again be a strong source of growth complementing the U.S. business, driven by the continued corn opportunity in Brazil and Argentina. In Argentina, the company has introduced Genuity® VT Triple PRO® corn as another product choice for farmers and expects the acceleration of the conversion of double stacks to the triple-stack product. Similarly, in Brazil, growers choosing to upgrade from single trait corn products to the first double stack, VT PRO? 2, is also expected to accelerate. Complementing the continued strong adoption of the company's next-generation soy platform in the United States, the Intacta RR2 PRO? soybean product is expected to be a driver of growth with expanded Ground Breakers? on-farm testing planned for 2013 as the product ramps up for commercial launch in Brazil and is introduced in other countries in coming years. Vegetable sales, up in the fourth quarter compared to the prior year period, were down year-over-year. In 2013, the company expects the vegetable business to return to growth and continues to anticipate it elevating to its third largest crop platform in terms of gross profit in the coming years. Cotton revenue decreased year-over-year due in part to acre shifts to other crops.Agricultural Productivity Segment Detail($ in millions)Net SalesGross ProfitFourth QuarterFiscal YearFourth QuarterFiscal Year20122011201220112012201120122011Agricultural Productivity$895$896$3,715$3,240$250$182$986$773TOTAL Agricultural Productivity$895$896$3,715$3,240$250$182$986$773 ($ in millions)Earnings (Loss) Before Interest & Taxes (EBIT)Agricultural ProductivityFourth QuarterFiscal Year2012201120122011EBIT (For a reconciliation of EBIT, see note 1.)$123$59$477$281Unusual Items Affecting EBIT:Restructuring$?$4$?$8EBIT from Discontinued Operations$2$(1)$10$3Nitro Claims Settlement$?$?$(44)$?The Agricultural Productivity segment consists of the crop protection products and lawn-and-garden herbicide products. Segment sales for the quarter reached $895 million with gross profit of $250 million.  For the fiscal year, the segment delivered net sales of $3.7 billion with gross profit of $986 million, with year-over-year increases that reflect strong performance from the company's Roundup®, lawn-and-garden and selective herbicides businesses.Webcast Information     In conjunction with this announcement, Monsanto will hold a conference call at 8:30 a.m. central time (9:30 a.m. eastern time) today. The call will focus on these results and future expectations and may include a discussion of Monsanto's strategic initiatives, product performance and other matters related to the company's business. Presentation slides and a simultaneous audio webcast of the conference call may be accessed by visiting the company's web site at or by visiting Visitors may need to download Windows Media Player? prior to listening to the webcast. Following the live broadcast, a replay of the webcast will be available on the Monsanto Web site for three weeks. About Monsanto CompanyMonsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit:  Follow our business on Twitter® at, on the company blog, Beyond the Rows® at, or subscribe to our News Release RSS Feed.Cautionary Statements Regarding Forward-Looking Information:Certain statements contained in this release are "forward-looking statements," such as statements concerning the company's anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: continued competition in seeds, traits and agricultural chemicals; the company's exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company's research and development activities; the outcomes of major lawsuits and the previously-announced SEC investigation; the previously reported material weakness in our internal controls over financial reporting; developments related to foreign currencies and economies; successful operation of recent acquisitions; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company's estimates related to distribution inventory levels; the company's ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company's facilities; and other risks and factors detailed in the company's most recent Form 10-K Report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this release. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results. Notes to editors: Monsanto and the Vine Design, DEKALB, Genuity, SmartStax, RIB Complete, VT Triple PRO, VT PRO 2, VT Double PRO, DroughtGard, Intacta RR2 PRO and Roundup Ready 2 Yield are trademarks of Monsanto Company and its wholly-owned subsidiaries. ContactMedia: Sara Miller (314-694-5824)Analysts: Bryan Hurley (314-694-8148) Monsanto Company Selected Financial Information(Dollars in millions, except per share amounts)Unaudited Statements of Consolidated Operations Three Months EndedTwelve Months EndedAug. 31,Aug. 31,2012201120122011Net Sales$2,110$2,247$13,516$11,822Cost of Goods Sold 1,2291,2756,4715,743Gross Profit8819727,0456,079Operating Expenses:Selling, general and administrative expenses7096472,3902,190Research and development expenses 4384031,5171,386Restructuring charges, net(10)(8)(10)1Total Operating Expenses1,1371,0423,8973,577Income (Loss) From Operations(256)(70)3,1482,502Interest Expense5245191162Interest Income(18)(23)(77)(74)Other Expense (Income), Net ?24640Income (Loss) from Continuing Operations Before Income Taxes(290)(94)2,9882,374Income Tax Provision (Benefit)(70)3901717Income (Loss) from Continuing Operations Including PortionAttributable to Noncontrolling Interest$(220)$(97)$2,087$1,657Discontinued Operations:Income (Loss) from Operations of Discontinued Businesses2(1)103Income Tax Provision1?41Income (Loss) on Discontinued Operations1(1)62Net Income (Loss)$(219)$(98)$2,093$1,659Less: Net Income Attributable to Noncontrolling Interest10144852Net Income (Loss) Attributable to Monsanto Company$(229)$(112)$2,045$1,607EBIT (see note 1)$(264)$(98)$3,047$2,387Basic Earnings (Loss) per Share Attributable to Monsanto Company:Income (Loss) from Continuing Operations$(0.43)$(0.21)$3.82$2.99Income on Discontinued Operations(0.01)?0.010.01Net Income (Loss) Attributable to Monsanto Company$(0.44)$(0.21)$3.83$3.00Diluted Earnings (Loss) per Share Attributable to Monsanto Company:Income (Loss) from Continuing Operations$(0.42)$(0.21)$3.78$2.96Income (Loss) on Discontinued Operations??0.01?Net Income (Loss) Attributable to Monsanto Company$(0.42)$(0.21)$3.79$2.96Weighted Average Shares Outstanding: Basic533.5535.1534.1536.5Diluted539.1540.8540.2542.4 Monsanto Company Selected Financial Information(Dollars in millions)Unaudited Condensed Statements of Consolidated Financial PositionAs ofAs ofAug. 31, 2012Aug. 31, 2011AssetsCurrent Assets:Cash and cash equivalents (variable interest entities restricted - 2012: $120 and 2011: $96)$3,283$2,572Short-term investments302302Trade receivables, net (variable interest entities restricted - 2012: $52 and 2011: $51)1,8972,117Miscellaneous receivables 622629Deferred tax assets597446Inventory, net2,8362,591Other current assets183152Total Current Assets9,7208,809Property, Plant and Equipment, Net4,3654,394Goodwill 3,4363,365Other Intangible Assets, Net1,2371,309Noncurrent Deferred Tax Assets488873Long-Term Receivables, Net376475Other Assets602619Total Assets$20,224$19,844Liabilities and Shareowners' EquityCurrent Liabilities:Short-term debt, including current portion of long-term debt36678Accounts payable 794839Income taxes payable75117Accrued compensation and benefits546427Accrued marketing programs1,2811,110Deferred revenues396373Grower production accruals19487Dividends payable200161Customer payable1494Restructuring reserves?24Miscellaneous short-term accruals685819Total Current Liabilities4,2214,729Long-Term Debt2,0381,543Postretirement Liabilities543509Long-Term Deferred Revenue245337Noncurrent Deferred Tax Liabilities313152Long-Term Portion of Environmental and Litigation Reserves213176Other Liabilities615682Monsanto Shareowners' Equity 11,83311,545Noncontrolling Interest203171Total Shareowners' Equity12,03611,716Total Liabilities and Shareowners' Equity$20,224$19,844Debt to Capital Ratio:15%16% Monsanto Company Selected Financial Information(Dollars in millions)Unaudited Statements of Consolidated Cash FlowsTwelve Months Ended Aug. 31,20122011Operating Activities:Net Income $2,093$1,659Adjustments to reconcile cash provided (required) by operating activities:Items that did not require (provide) cash:Depreciation and amortization 622613Bad-debt expense33Stock-based compensation expense128104Excess tax benefits from stock-based compensation(50)(36)Deferred income taxes292135Restructuring charges, net(10)1Equity affiliate income, net(19)(21)Net gain on sales of a business or other assets(4)(5)Other items10581Changes in assets and liabilities that provided (required) cash, net of acquisitions:Trade receivables, net89(310)Inventory, net(419)156Deferred revenues(43)62Accounts payable and other accrued liabilities379894Restructuring cash payments(12)(183)Pension contributions(83)(291)Other items(20)(48)Net Cash Provided by Operating Activities3,0512,814Cash Flows Provided (Required) by Investing Activities:Purchases of short-term investments(746)(732)Maturities of short-term investments746430Capital expenditures(646)(540)Acquisitions of businesses, net of cash acquired(322)(99)Technology and other investments(77)(55)Other investments and property disposal proceeds1121Net Cash Required by Investing Activities(1,034)(975)Cash Flows Provided (Required) by Financing Activities:Net change in financing with less than 90-day maturities(116)69Short-term debt proceeds3084Short-term debt reductions(42)(74)Long-term debt proceeds499299Long-term debt reductions(629)(193)Payments on other financing?(1)Debt issuance costs(5)(5)Treasury stock purchases(432)(502)Stock option exercises11765Excess tax benefits from stock-based compensation5036Tax withholding on restricted stock and restricted stock units(19)(4)Dividend payments(642)(602)Proceeds from noncontrolling interests10169Dividend payments to noncontrolling interests(77)(105)Net Cash Required by Financing Activities(1,165)(864)Cash Assumed from Initial Consolidations of Variable Interest Entities?77Effect of Exchange Rate Changes on Cash and Cash Equivalents(141)35Net Increase in Cash and Cash Equivalents7111,087Cash and Cash Equivalents at Beginning of Period2,5721,485Cash and Cash Equivalents at End of Period$3,283$2,572 Monsanto CompanySelected Financial Information(Dollars in millions, except per share amounts)Unaudited1.EBIT, Ongoing EPS and Free Cash Flow: The presentations of EBIT, ongoing EPS and free cash flow are not intended to replace net income (loss) attributable to Monsanto Company, cash flows, financial position or comprehensive income (loss), and they are not measures of financial performance as determined in accordance with generally accepted accounting principles (GAAP) in the United States. The following tables reconcile EBIT, ongoing EPS and free cash flow to the respective most directly comparable financial measure calculated in accordance with GAAP. Reconciliation of EBIT to Net Income (Loss): EBIT is defined as earnings (loss) before interest and taxes. Earnings (loss) is intended to mean net income (loss) attributable to Monsanto Company as presented in the Statements of Consolidated Operations under GAAP. The following table reconciles EBIT to the most directly comparable financial measure, which is net income (loss) attributable to Monsanto. Three Months EndedTwelve Months EndedAug. 31,Aug. 31,2012 201120122011EBIT ? Seeds and Genomics Segment $(387)$(157)$2,570$2,106EBIT ? Agricultural Productivity Segment 123 59477281EBIT? Total  (264)(98)3,0472,387Interest Expense, Net 34 2211488Income Tax Provision (Benefit)(A) (69)(8)888692Net Income (Loss) Attributable to Monsanto Company$(229)$(112)$2,045$1,607 (A)Includes the income tax provision from continuing operations, the income tax provision (benefit) on noncontrolling interest, and the income tax provision on discontinued operations.Reconciliation of EPS to Ongoing EPS:  Ongoing EPS is calculated excluding certain after-tax items which Monsanto does not consider part of ongoing operations. Fiscal YearThree Months EndedTwelve Months Ended2013Aug. 31,Aug. 31,Guidance2012201120122011Diluted Earnings (Loss) per Share$4.18-$4.32$(0.42)$(0.21)$3.79$2.96Restructuring Charges, Net?(0.02)(0.01)(0.02)?Income on Discontinued Operations???(0.01)?Nitro Claims Settlement???0.05?Resolution of a Legacy Tax Matter???(0.11)?Diluted Earnings (Loss) per Share from Ongoing Business$4.18-$4.32$(0.44)$(0.22)$3.70$2.96 Reconciliation of Free Cash Flow: Free cash flow represents the total of cash flows from operating activities and investing activities, as reflected in the Statements of Consolidated Cash Flows presented in this release. With respect to the fiscal year 2013 free cash flow guidance, Monsanto does not include any estimates or projections of Net Cash Provided (Required) by Financing Activities because in order to prepare any such estimate or projection, Monsanto would need to rely on market factors and conditions that are outside of its control.Fiscal Year Twelve Months Ended2013Aug. 31,Guidance20122011Net Cash Provided by Operating Activities$2,800-3,100$3,051$2,814Net Cash Required by Investing Activities (1,100)-(1,300)(1,034)(975)Free Cash Flow$1,700-1,800$2,017$1,839Net Cash Required by Financing ActivitiesN/A(1,165)(864)Cash Assumed from Initial Consolidations of Variable Interest EntitiesN/A?77Effect of Exchange Rate Changes on Cash and Cash EquivalentsN/A(141)35Net Increase in Cash and Cash EquivalentsN/A7111,087Cash and Cash Equivalents at Beginning of PeriodN/A2,5721,485Cash and Cash Equivalents at End of PeriodN/A$3,283$2,572SOURCE Monsanto Company